Luke M. Beshar, EVP & CFO at NPS PHARMACEUTICALS INC (NPSP), sold 45,000 shares at $30.43 ($1.4M) on 2013-09-20, disclosed to the SEC on 2013-09-24.
Scheduled sale ($1.4M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.15 | 19,000 | $573K | 42.0% |
| 2 | $30.32 | 12,000 | $364K | 26.7% |
| 3 | $30.43 | 14,000 | $426K | 31.3% |
| Total | $30.28 avg | 45,000 | $1.4M | 100% |
| Filing → |
| TARA | BUY | 2022-03-14 | $45K | — | Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |